| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25753424a1aa4ae0a613f0f88b22d053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfc758d92643d4710fae8388f9354d71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8adf1aa119f2fa8c92dc31e5ef07b387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31b60ceda51a5cc78d524c7a24e89dd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_563890a24eea2638b486dcbae7745173
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb0e20724213f7343449a6fc6f7a4144 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-42 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404 |
| filingDate |
2006-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35cac5e4c09e561eba900a1067397530
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e27c45c0514f4788bd5c3d6eeca15f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8f408b9af1e770fc2a2dca86cb5f2ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12bf4040966aae3317f5f398ab14bde3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3959ed14d046f69a403f2ee9ae91e1b0 |
| publicationDate |
2006-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006082400-A1 |
| titleOfInvention |
Indan-amide derivatives with glycogen phosphorylase inhibitory activity |
| abstract |
A compound of the formula (1) or a pharmaceutically-acceptable salt: (A chemical formula should be inserted here - please see paper copy enclosed herewith) (1) possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity. Processes for the manufacture of compounds and pharmaceutical compositions containing them are described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8889878-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943658-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8710242-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2351568-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011054436-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009015169-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007128761-A2 |
| priorityDate |
2005-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |